Ulcerative Colitis

But once my body had got used to taking the knocks, I didn't notice."A Rushton Promotions' show whetted Brigg-based Harring ton's appetite for boxing."I told John Rushton that I would like to do a bit of boxing.

He said I was welcome to train at his gym."Harrington quickly won the admiration of his stablemates."I can't wait to step into the ring.

I'm determined to do myself justice.

"John has given me a lot of support and I don't want let him, or myself, down."I have a lot to learn and am not going to make any rash predictions.

But I'm determined to get my career off to a winning start."Tickets: 01302 310919.

04 February 2006 « Previous Page Next » Page 1 of 1 More Sport Search O...

• Diet and exercise: A diet high in fat, particularly from animal sources and an inactive, sedentary lifestyle can increase a person's chance of developing colon cancer.

• Smoking and alcohol: Research suggests that smokers and heavy drinkers have an increased chance of developing colon cancer.

Knowing your family history is important in screening for colorectal cancer.

If there are cases of polyps or colorectal cancer in your family, your doctor may recommend a colonoscopy or other tests prior to age 50.

However, if your family doesn’t have a history of the disease—and you’re age 50 or older—the following procedures are recommended: • A stool blood test, also known as a fecal occult blood test, every year.

A fecal occult blood test is designed to find tiny amounts of hidden blood in the stool.

Patients receive a kit that instructs them how to take stool samples at home.

The kit is then taken to a lab for testing.

Also recommended is a flexible sigmoidoscopy, an exam of the lower section of the colon and rectum.

The lower colon and rectum is the location of most polyps and cancers.

Recommended every five years.

OR • Colonoscopy, which examines the entire colon and rectum.

It is recommended ever...

Korzenik, both for patients who need pain relief and for their gastroenterologists, who are concerned with the safety of painkilling medications.

In the Mayo Clinic study, William Sandborn, M.D., and colleagues randomized 22 patients with The study found no significant differences: 3% of patients getting Celebrex had a disease exacerbation, compared with 4% in the placebo group.

11% of patients in each group had a bowel-related adverse event 5% of patients in the Celebrex group and 3% of patients in the placebo group withdrew because of adverse events.

The study has limitations, Dr.

Sandborn and colleagues noted.

The duration was short, it did not include patients who were in exacerbation, and patients in the study were on maintenance therapy with 5-aminosalicylate medications and/or azathioprine or 6-mercaptopurine.

Also, the researchers did not attempt to evaluate how well Celebrex worked for pain relief in these patients.

Several members of the study team are employed by Pfizer, which makes Celebrex.

In the European study, researchers led by Ingvar Bjarnason, M.D., of Sahlgrenska Un...